The Impact of Standardizing Preoperative Diabetic Medication Instruction and Glucose Optimization on Postoperative Patient Outcomes

Authors

  • Olivia Calisi Pennsylvania State University College of Medicine https://orcid.org/0000-0001-7981-8494
  • Gilles Dongmo Department of Anesthesiology and Perioperative Medicine, Penn State Milton S. Hershey Medical Center
  • Selina Read Department of Anesthesiology and Perioperative Medicine, Penn State Milton S. Hershey Medical Center https://orcid.org/0000-0002-0429-2130

DOI:

https://doi.org/10.26209/psjm62882

Keywords:

preoperative diabetes management, anesthesia preoperative evaluation

Abstract

Purpose: 

The purpose of this project was to evaluate the effectiveness of a standardized preoperative diabetic medication instruction program in patients with diabetes undergoing elective noncardiac surgical procedures. In particular, we measured postoperative blood glucose levels and surgical complication rates to assess the success of the program.

Methods:

A retrospective review was performed on adult patients who were on oral hypoglycemic or insulin medication for diabetes mellitus type I and II, were undergoing elective non-cardiac surgery, and had been evaluated by the anesthesia preoperative clinic before and after standardization of medication instruction. Analysis was performed for the primary outcomes of postoperative glucose levels on post-op day 0 and secondary outcomes of surgical complications.

Results:

There were 167 patients in the pre-standardization protocol, and 183 patients in the post-standardization protocol, for a total of 350 patients. There was no significant difference between pre- and post-standardization protocols for postoperative glucose levels (158.5 ±63.22 vs. 154.3 ±56.32, P=0.52) nor secondary outcomes such as time to discharge in days (4.79 ±0.95 vs. 4.55 ±0.94, P=0.73), postoperative surgical site infection (odds ratio [OR], 13.77; 95% confidence interval [CI], [0.40, 471.1]), postoperative infection (OR=0.62; 95% CI [0.22, 1.73]), diabetes complications such as diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome (OR=1.29; 95% CI [0.04, 43.08]), readmission to the hospital within 30-days (OR=1.15; 95% CI [0.40, 43.08]), and return to the operating room (OR=0.61; 95% CI [0.21, 1.73]).

Conclusion:

There is no statistically significant difference in the measured perioperative outcomes before and after the standardization of preoperative diabetic medication instruction. This is most likely due to a low observation of surgical complications. Future studies may include larger populations to further evaluate the efficacy of a standardized preoperative diabetic medication instruction program.

Downloads

Published

2023-04-14